The award recognized Titan Spine’s research paper “Implant Materials Generate Different Peri-Implant Inflammatory Factors: PEEK Promotes Fibrosis and Micro-Textured Titanium Promotes Osteogenic Factors.”
The paper was presented by Titan Spine CMO Paul Slosar, MD, of Spine Care Medical Group in San Francisco.
The study served to compare the company’s Endoskeleton Interbody Devices to devices made from PEEK.
More Articles on Devices:
MedTech Receive CE Mark for Robotic Spinal Surgery System
8 Trends in the Surgical Navigation Systems Market
Biomet, Medtronic, Misonix & More – 7 Key Notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
